PortfoliosLab logoPortfoliosLab logo
KRYS vs. SPY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

KRYS vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Krystal Biotech, Inc. (KRYS) and State Street SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, KRYS achieves a 38.63% return, which is significantly higher than SPY's 10.67% return.


KRYS

1D
-2.41%
1M
5.70%
6M
21.20%
YTD
38.63%
1Y
127.74%
3Y*
38.78%
5Y*
39.99%
10Y*

SPY

1D
-0.54%
1M
0.31%
6M
9.02%
YTD
10.67%
1Y
21.60%
3Y*
20.01%
5Y*
13.24%
10Y*
15.08%
*Multi-year figures are annualized to reflect compound growth (CAGR)

KRYS vs. SPY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
KRYS
Krystal Biotech, Inc.
38.63%57.37%26.28%56.60%13.25%16.58%8.34%166.51%97.53%0.19%
SPY
State Street SPDR S&P 500 ETF
10.67%17.72%24.89%26.18%-18.18%28.73%18.33%31.22%-4.57%7.30%

Correlation

The correlation between KRYS and SPY is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.33

Correlation (3Y)
Calculated over the trailing 3-year period

0.39

Correlation (5Y)
Calculated over the trailing 5-year period

0.40

Correlation (All Time)
Calculated using the full available price history since Sep 20, 2017

0.36

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

KRYS vs. SPY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

KRYS
KRYS Risk / Return Rank: 9696
Overall Rank
KRYS Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
KRYS Sortino Ratio Rank: 9595
Sortino Ratio Rank
KRYS Omega Ratio Rank: 9595
Omega Ratio Rank
KRYS Calmar Ratio Rank: 9898
Calmar Ratio Rank
KRYS Martin Ratio Rank: 9797
Martin Ratio Rank

SPY
SPY Risk / Return Rank: 6565
Overall Rank
SPY Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
SPY Sortino Ratio Rank: 6363
Sortino Ratio Rank
SPY Omega Ratio Rank: 6565
Omega Ratio Rank
SPY Calmar Ratio Rank: 6161
Calmar Ratio Rank
SPY Martin Ratio Rank: 7373
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

KRYS vs. SPY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Krystal Biotech, Inc. (KRYS) and State Street SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


KRYSSPYDifference
Sharpe ratioReturn per unit of total volatility

+1.53

Sortino ratioReturn per unit of downside risk

+1.12

Omega ratioGain probability vs. loss probability

1.48

1.31

+0.17

Calmar ratioReturn relative to maximum drawdown

8.06

2.44

+5.62

Martin ratioReturn relative to average drawdown

20.74

10.63

+10.11

KRYS vs. SPY - Sharpe Ratio Comparison

The current KRYS Sharpe Ratio is 3.25, which is higher than the SPY Sharpe Ratio of 1.72. The chart below compares the historical Sharpe Ratios of KRYS and SPY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

KRYS vs. SPY - Drawdown Comparison

The maximum KRYS drawdown since its inception was -53.42%, roughly equal to the maximum SPY drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for KRYS and SPY.


Loading charts...

Drawdown Indicators


KRYSSPYDifference

Max Drawdown

Largest peak-to-trough decline

-53.42%

-55.19%

+1.77%

Max Drawdown (1Y)

Largest decline over 1 year

-15.94%

-8.88%

-7.06%

Max Drawdown (3Y)

Largest decline over 3 years

-42.26%

-18.76%

-23.50%

Max Drawdown (5Y)

Largest decline over 5 years

-44.55%

-24.50%

-20.05%

Max Drawdown (10Y)

Largest decline over 10 years

-33.72%

Current Drawdown

Current decline from peak

-9.62%

-0.91%

-8.71%

Average Drawdown

Average peak-to-trough decline

-16.03%

-9.02%

-7.01%

Ulcer Index

Depth and duration of drawdowns from previous peaks

6.18%

2.04%

+4.14%

Volatility

KRYS vs. SPY - Volatility Comparison

Krystal Biotech, Inc. (KRYS) has a higher volatility of 12.22% compared to State Street SPDR S&P 500 ETF (SPY) at 3.58%. This indicates that KRYS's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


KRYSSPYDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.22%

3.58%

+8.64%

Volatility (6M)

Calculated over the trailing 6-month period

27.17%

10.02%

+17.15%

Volatility (1Y)

Calculated over the trailing 1-year period

39.52%

12.58%

+26.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

76.45%

17.17%

+59.28%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

73.86%

17.93%

+55.93%

Dividends

KRYS vs. SPY - Dividend Comparison

KRYS has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.00%.


PositionTTM20252024202320222021202020192018201720162015
KRYS
Krystal Biotech, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
State Street SPDR S&P 500 ETF
1.00%1.07%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%

Frequently Asked Questions


KRYS and SPY have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

KRYS has higher volatility (12.22%) compared to SPY (3.58%). In terms of maximum drawdown, KRYS dropped -53.42% vs SPY's -55.19%.

KRYS currently has the higher Sharpe Ratio (3.25 vs 1.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for KRYS and SPY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer